Corbus Pharmaceuticals Raises $16.8 Million from Stock Sale

Corbus Pharmaceuticals (CRBP) has released an update.

Corbus Pharmaceuticals Holdings, Inc. has generated approximately $16.8 million from the sale of common stock and expects to report $20.9 million in cash, cash equivalents, and investments as of year-end 2023, including $13.7 million in cash and cash equivalents. These preliminary figures are subject to final adjustments following the company’s financial closing procedures. The provided financial data has not been audited or reviewed by the company’s independent accountants and should not be considered a substitute for official financial statements.

For further insights into CRBP stock, check out TipRanks’ Stock Analysis page.